ADIL vs ACHV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACHV Captures Institutional Edge (3โ1 Pillars ยท 6โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Achieve Life Sciences, Inc. (ACHV) driven by superior Valuation, Growth & Margin, Options & Structure while ADIL counters with relative strength in Momentum & Technical. Fundamentally, ADIL trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ACHV at 35.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ADIL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ADIL | ACHV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $9.7M | $692.8M | Larger Scale | ACHV |
| Trailing P/E Ratio Valuation | N/M | 35.3x | Lower Multiple | ACHV |
| Forward P/E Ratio Valuation | N/M | 35.3x | Lower Multiple | ACHV |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -2011.6% | -845.0% | Higher ROE | ACHV |
| 52-Week Range Position Momentum | 70% ($0โ$7) | 69% ($3โ$9) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.63ฮฒ ยท 153% Vol | 1.73ฮฒ ยท 62% Vol | Lower Realized Risk | ACHV |
| Unified Institutional Score Composite Signal | 32.8 / 100 (SELL) | 56.6 / 100 (HOLD) | Higher Composite | ACHV |